12:00 AM
 | 
Aug 06, 2012
 |  BC Week In Review  |  Company News  |  Deals

Anchor Therapeutics, Kyowa Hakko Kirin deal

The companies partnered to use Anchor's pepducin technology to advance Kyowa's GPCR drug discovery portfolio. The partners will also develop pepducin therapeutics and use the pepducin...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >